BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20135922)

  • 41. Leptomeningeal carcinomatosis: a sequela of cholangiocarcinoma.
    Huffman JL; Yeatman TJ; Smith JB
    Am Surg; 1997 Apr; 63(4):310-3. PubMed ID: 9124747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
    Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
    World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome.
    Ratti F; Cipriani F; Ferla F; Catena M; Paganelli M; Aldrighetti LA
    World J Surg; 2013 Jun; 37(6):1388-96. PubMed ID: 23494083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic duct stones masquerading as Klatskin tumour.
    Dixit VK; Chaturvedi P; Pandey M; Agarwal AK; Shukla VK
    J Assoc Physicians India; 1999 Feb; 47(2):236-7. PubMed ID: 10999099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endoscopic ultrasound for cholangiocarcinoma re-evaluation after Wallstent placement.
    Iglesias-García J; Lariño-Noia J; Seijo-Ríos S; Domínguez-Muñoz JE
    Rev Esp Enferm Dig; 2008 Apr; 100(4):236-7. PubMed ID: 18563982
    [No Abstract]   [Full Text] [Related]  

  • 46. [An update in the diagnosis and treatment of tumors of the hepatic portal].
    Vadalà G; Ponzio R; Pappalardo G; Salice M; Castorina R; Polara R; Buffone A
    Minerva Chir; 1998 Sep; 53(9):701-7. PubMed ID: 9866935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Portal vein leiomyosarcoma: A rare case of hepatic hilar tumor with review of the literature.
    Gaignard E; Bergeat D; Stock N; Robin F; Boudjema K; Sulpice L; Rayar M; Meunier B
    Indian J Cancer; 2019; 56(1):83-85. PubMed ID: 30950452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aneurysm of the portal vein due to an infiltrating cholangiocarcinoma].
    Hausegger KW; Fuhrmann W; Jilek K; Stangl F; Stering R
    Rofo; 1992 Oct; 157(4):431-2. PubMed ID: 1327274
    [No Abstract]   [Full Text] [Related]  

  • 49. Extrahepatic cholangiocarcinoma with prolonged survival: a case report.
    Al-Zahir MZ; AlAmeel T
    J Med Case Rep; 2017 Dec; 11(1):357. PubMed ID: 29275776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Favourable anatomical variation for the resection of a Klatskin tumour.
    La Greca G; Racalbuto A; Puleo S; Licata A
    Eur J Surg Oncol; 1996 Feb; 22(1):97-101. PubMed ID: 8846879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transparenchymal glissonean approach: a novel surgical technique for advanced perihilar bile duct cancer.
    Kamachi H; Kamiyama T; Tsuruga Y; Orimo T; Wakayama K; Shimada S; Kakisaka T; Yokoo H; Yamashita K; Taketomi A
    Langenbecks Arch Surg; 2018 May; 403(3):387-394. PubMed ID: 29063245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgicopathologic correlations regarding lymphatics in hilar cholangiocarcinoma.
    Roncati L; Manenti A; Pavesi E; Piscioli F; Farinetti A; Pusiol T
    Surgery; 2016 May; 159(5):1483. PubMed ID: 26883162
    [No Abstract]   [Full Text] [Related]  

  • 53. An intraluminal lesion in the mid-common bile duct and right hepatic duct causing right portal vein obstruction.
    Ball CG; Gmora S; Vollmer CM; Dixon E
    J Hepatol; 2004 Dec; 41(6):1060. PubMed ID: 15582143
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis.
    Song Y; Zhang Y; Zhen Z; Huang Z
    World J Surg Oncol; 2022 Jul; 20(1):230. PubMed ID: 35821140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical Considerations of Hilar Cholangiocarcinoma.
    Anderson B; Doyle MBM
    Surg Oncol Clin N Am; 2019 Oct; 28(4):601-617. PubMed ID: 31472908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of ALPPS in surgery for Klatskin tumours.
    Nagino M
    Br J Surg; 2019 Nov; 106(12):1574-1575. PubMed ID: 31639206
    [No Abstract]   [Full Text] [Related]  

  • 57. [Intrahepatic cholangiocarcinoma and perihilar cholangiocarcinoma -differentiation in terms of imaging diagnoses and surgical procedures].
    Aoki T; Kubota K
    Nihon Shokakibyo Gakkai Zasshi; 2016 Sep; 113(9):1550-6. PubMed ID: 27593364
    [No Abstract]   [Full Text] [Related]  

  • 58. Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors.
    Liu CL; Lo CM; Lai EC; Fan ST
    Arch Surg; 1998 Mar; 133(3):293-6. PubMed ID: 9517743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proximal bile duct cancer: high resectability rate and 5-year survival.
    Launois B; Terblanche J; Lakehal M; Catheline JM; Bardaxoglou E; Landen S; Campion JP; Sutherland F; Meunier B
    Ann Surg; 1999 Aug; 230(2):266-75. PubMed ID: 10450742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Surgical therapy of proximal extrahepatic bile duct tumors (Klatskin tumors)].
    Timm S; Gassel HJ; Thiede A
    Zentralbl Chir; 2007 Aug; 132(4):328-35. PubMed ID: 17724636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.